Evidence map›Paper›PMID 31782084›Full record

ArticleMolecular and cellular biochemistry2020

Inhibition of polo-like kinase 1 suppresses microtubule dynamics in MCF-7 cells.

Aijaz Rashid, Afsana Naaz, Ankit Rai, Biswa Prasun Chatterji, Dulal Panda

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Aijaz RashidDepartment of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, 400076, India.
Afsana NaazDepartment of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, 400076, India.
Ankit RaiDepartment of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, 400076, India.
Biswa Prasun ChatterjiDepartment of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, 400076, India.
Dulal PandaDepartment of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, 400076, India. panda@iitb.ac.in.ORCID http://orcid.org/0000-0002-9885-4500
Indian Institute of Technology Bombay · IN

Funding

Department of Biotechnology, Government of India BT/PR13319/BRB/10/762/2009
6 · The paper itself

Abstract

Polo-like kinase 1 (Plk1) is a mitotic serine/threonine kinase implicated in spindle formation and cytokinesis in mammalian cells. Here, purified Plk1 was found to bind to reconstituted microtubules in vitro. Further, Plk1 was found to co-localize with interphase microtubules in MCF-7 cells and to co-immunoprecipitate with polymerized tubulin. The binding of Plk1 to interphase microtubules appeared to increase with an increase in the level of tubulin acetylation in MCF-7 cells. Interestingly, Plk1 inhibitor III, an inhibitor of Plk1 kinase activity, treatment increased the association of Plk1 with the interphase microtubules in MCF-7 cells. Therefore, the effect of inhibition of Plk1 kinase activity on the dynamic instability of microtubules was determined by time-lapse imaging in MCF-7 cells. Plk1 inhibitor III dampened the dynamic instability of microtubules. For example, Plk1 inhibitor III (3 μM) reduced the rate and extent of the growing phase by 28 and 48%, respectively, and inhibited the dynamicity of microtubules by 53% as compared to the microtubules in control MCF-7 cells. Plk1 inhibitor III treatment also increased the level of acetylated microtubules, indicating that it stabilizes microtubules. The findings indicated that Plk1 interacts with microtubules and Plk1 may have a role in the regulation of microtubule dynamics.

Indexed as

Cell Cycle ProteinsFemaleHumansMCF-7 CellsMicrotubulesPolo-Like Kinase 1Protein Kinase InhibitorsProtein Serine-Threonine KinasesProto-Oncogene ProteinsTubulinCell Cycle ProteinsPolo-Like Kinase 1Protein Kinase InhibitorsProtein Serine-Threonine KinasesProto-Oncogene ProteinsTubulinMicrotubule dynamicsPolo-like kinase 1 inhibitor IIISerine/threonine kinaseTrichostatin ATubulin acetylation

Identifiers

PMID31782084
OpenAlexW2990419678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.